| Financial Year |
March 31 2023 |
| Monetary Funds |
682,517,676.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
278,025,640.68 |
| Accounts Receivable |
143,905,435.54 |
| Advances to Suppliers |
55,988,394.56 |
| Other Receivables |
212,556.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
428,662,418.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
224,057,053.26 |
| Total Current Assets |
1,957,707,566.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,944,914.88 |
| Investment Properties |
167,647,145.00 |
| Fixed Assetes |
580,033,185.56 |
| Under-construction Projects |
76,671,718.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,656,218.99 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
14,542,088.45 |
| Other Non-Current Assets |
113,714,319.63 |
| Sub-Total of Non-Current Assets |
1,328,449,591.35 |
| Total Assets |
3,286,157,158.21 |
| Short-Term Loans |
807,638,505.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
510,590,000.00 |
| Accounts Payable |
243,946,756.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,218,132.16 |
| Taxes Payable |
2,935,881.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,578,983.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
123,175,502.05 |
| Other Current Liabilities |
4,037,900.54 |
| Sub-Total of Current Liabilities |
1,772,898,805.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
102,063,305.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
111,363,305.44 |
| Total Liabilities |
1,884,262,111.41 |
| Paid-In Capital(Or Share Stock) |
528,139,623.00 |
| Capital Surplus |
627,762,424.19 |
| Surplus Reserve |
97,982,866.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
152,539,836.47 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,401,895,046.80 |
| Owner's Equity（Stockholder's Equity） |
1,401,895,046.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,286,157,158.21 |
